{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Special Blood Product Requirements of Acute Promyelocytic Leukemia
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on the use of blood products for the treatment of acute promyelocytic leukemia (APL).Learning Objectives
After completing this continuing education activity you will be able to:
- Discuss the pathophysiology of APL and the risk for severe hemorrhage in patients with the disease.
- Select appropriate treatments for a patient with APL.
Disclosures
The author and planners have disclosed no potentil conflicts of interest, financial or otherwise.
Price:
$17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT0416
Published: Apr 2016
Expires: 12/31/2026
Sources:
Oncology Times
Required Passing Score: 7/10 (70%)
Specialties:
Oncology